Cancer is a complex disease driven by genetic mutations. Understanding these mutations requires access to vast amounts of genomic data. The GA4GH facilitates this by promoting data sharing and interoperability, which are critical for identifying new cancer biomarkers, understanding cancer progression, and developing targeted therapies.
